Predictors Of Outcome After Coronary Artery Bypass Graft Surgery Using Cardiopulmonary Bypass

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAlexandria University

About this trial

In cardiac operations, high values of blood lactate have been associated with bad outcomes if detected both during CPB and at the arrival in the intensive care unit (ICU) in adult patients. Many studies highlighted the potential role of hyperlactatemia on admission to the ICU as a marker for adverse outcome, and one study linked hyperlactatemia during CPB with postoperative morbidity and mortality. Evidence that both CENTRAL VENOUS SATURATION (ScVO2) and blood lactates during CPB are potential early predictors of morbidity and mortality in adult cardiac operations are still lacking.

Eligibility criteria

Qualifiers

Aged 18 years or above.

Operated with cardiopulmonary bypass.

Disqualifiers

Preoperative lactate level greater than 3 mmol/l.

Redo surgery.

If the patient will be reoperated during the study time.

Preoperative hemoglobin level less than 10 mg/dl.

Trial design

Treatments tested in this trial

  • CORONARY BYPASS SURGERY USING CARDIOPULMONARY BYPASS
  • cardiac surgical patients who will undergo isolated elective cardiopulmonary bypass

Treatment groups

60 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators